Impel NeuroPharma Inc. Made Big Gain
Wed, Nov 01, 2023 at 07:39 PM
Impel NeuroPharma Inc. (IMPL:NASDAQ) rocketted at $0.29, representing a gain of 31.4%. The stock got featured on our News Catalysts scanner on Mon, Oct 30, 2023 at 05:06 PM in the 'MISCELLANEOUS' category. From Wed, Oct 18, 2023, the stock recorded 40.00% Up Days and 18.18% Green Days
About Impel NeuroPharma Inc. (IMPL:NASDAQ)
Impel NeuroPharma Inc is a late-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases...
Top 10 Gainers:
- Cellectis S.A. (CLLS:NASDAQ), 173.86%
- Patriot Transportation Holding, Inc. (PATI:NASDAQ), 103.13%
- Aldeyra Therapeutics, Inc. (ALDX:NASDAQ), 48.54%
- Sientra, Inc. (SIEN:NASDAQ), 32.95%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 31.45%
- PMV Pharmaceuticals Inc. (PMVP:NASDAQ), 31.13%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 30.92%
- Local Bounti Corporation (LOCL:NYSE), 30.12%
- Precision BioSciences, Inc. (DTIL:NASDAQ), 29.63%
- Silence Therapeutics Plc (SLN:NASDAQ), 29.25%